These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 2502066

  • 1. Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis.
    Chamberland S, Bayer AS, Schollaardt T, Wong SA, Bryan LE.
    Antimicrob Agents Chemother; 1989 May; 33(5):624-34. PubMed ID: 2502066
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of high-level resistance to quinolones in urinary tract isolates of Pseudomonas aeruginosa.
    Yoshida T, Muratani T, Iyobe S, Mitsuhashi S.
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1466-9. PubMed ID: 7979273
    [Abstract] [Full Text] [Related]

  • 3. Persistence of Pseudomonas aeruginosa during ciprofloxacin therapy of a cystic fibrosis patient: transient resistance to quinolones and protein F-deficiency.
    Chamberland S, Malouin F, Rabin HR, Schollaardt T, Parr TR, Bryan LE.
    J Antimicrob Chemother; 1990 Jun; 25(6):995-1010. PubMed ID: 2115039
    [Abstract] [Full Text] [Related]

  • 4. nfxC-type quinolone resistance in a clinical isolate of Pseudomonas aeruginosa.
    Fukuda H, Hosaka M, Iyobe S, Gotoh N, Nishino T, Hirai K.
    Antimicrob Agents Chemother; 1995 Mar; 39(3):790-2. PubMed ID: 7793896
    [Abstract] [Full Text] [Related]

  • 5. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction.
    Cohen SP, McMurry LM, Hooper DC, Wolfson JS, Levy SB.
    Antimicrob Agents Chemother; 1989 Aug; 33(8):1318-25. PubMed ID: 2679373
    [Abstract] [Full Text] [Related]

  • 6. Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
    Aubert G, Pozzetto B, Dorche G.
    J Antimicrob Chemother; 1992 Mar; 29(3):307-12. PubMed ID: 1317371
    [Abstract] [Full Text] [Related]

  • 7. Development of beta-lactam resistance and increased quinolone MICs during therapy of experimental Pseudomonas aeruginosa endocarditis.
    Bayer AS, Hirano L, Yih J.
    Antimicrob Agents Chemother; 1988 Feb; 32(2):231-5. PubMed ID: 3129985
    [Abstract] [Full Text] [Related]

  • 8. [Resistance to quinolones and beta-lactams in Salmonella enterica due to mutations in topoisomerase-encoding genes, altered cell permeability and expression of an active efflux system].
    Miró E, Vergés C, García I, Mirelis B, Navarro F, Coll P, Prats G, Martínez-Martínez L.
    Enferm Infecc Microbiol Clin; 2004 Apr; 22(4):204-11. PubMed ID: 15056435
    [Abstract] [Full Text] [Related]

  • 9. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin.
    Li XZ, Livermore DM, Nikaido H.
    Antimicrob Agents Chemother; 1994 Aug; 38(8):1732-41. PubMed ID: 7986003
    [Abstract] [Full Text] [Related]

  • 10. New norfloxacin resistance gene in Pseudomonas aeruginosa PAO.
    Fukuda H, Hosaka M, Hirai K, Iyobe S.
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1757-61. PubMed ID: 2126688
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis.
    Michéa-Hamzehpour M, Auckenthaler R, Regamey P, Pechère JC.
    Antimicrob Agents Chemother; 1987 Nov; 31(11):1803-8. PubMed ID: 3124739
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation.
    Hooper DC, Wolfson JS, Souza KS, Ng EY, McHugh GL, Swartz MN.
    Antimicrob Agents Chemother; 1989 Mar; 33(3):283-90. PubMed ID: 2658782
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.